DGAT2 and metabolic dysfunction-associated steatohepatitis: As discussed earlier, TAG synthesis might prevent the toxic effects of FFA accumulation in hepatocytes [27], and DGAT2 inhibition to treat NAFLD and/or NASH was met with skepticism.